文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

新冠病毒感染相关血栓形成中脂质介质和氧化脂质的分析

Profiling of lipid mediators and oxylipins in SARS-CoV-2 infection associated thrombosis.

作者信息

Peng Daibao, Chen Fei, Sun Haixuan, Xia Mao

机构信息

Department of Clinical Laboratory Medicine, Taikang Xianlin Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.

Department of Clinical Laboratory, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, 210008, China.

出版信息

Sci Rep. 2025 Aug 29;15(1):31904. doi: 10.1038/s41598-025-17722-7.


DOI:10.1038/s41598-025-17722-7
PMID:40883531
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12397397/
Abstract

Thrombosis is a life-threatening complication in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. This study aims to conduct a statistical analysis of the incidence of blood clots and lipid concentrations, and to examine the networks of oxylipins in hospitalised patients with SARS-CoV-2. Serum samples of 1731 hospitalised patients with SARS-COV-2 were used to measure six lipid parameters: total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), apolipoprotein A (apoA), and apolipoprotein B (apoB). Additionally, the lipid profiles and oxidative lipidomics characteristics were examined via liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-MS/MS) in SARS-COV-2-positive patients with and without thrombosis. The mortality rate in the SARS-COV-2 thrombosis group was significantly higher at 29.6% compared to the SARS-COV-2 non-thrombosis group at 12.1% (P < 0.0001). The levels of the lipid parameters were closely associated with both thrombosis and SARS-COV-2 severity. Patients with SARS-COV-2 admitted to the hospital exhibited significant changes in oxidative lipid metabolites, specifically in the arachidonic acid (ARA) and docosahexaenoic acid (DHA) classes, compared with those in the control group. Among the thrombus group, 28 oxidative lipid metabolites were found to be differentially expressed compared to the non-thrombus group, and with the most notable variations observed in 20-hydroxyPGF2α and 14(15)-EpETE. Enrichment analysis using KEGG revealed that differential oxidized lipid metabolites mainly concentrated in the ARA and serotonergic synapses metabolism signaling pathway. Our findings indicate a close association between lipid mediators and both SARS-COV-2 and thrombi. Specifically, ARA and serotonergic synapses metabolism signaling pathway may be an important pathogenic factor for thrombosis caused by SARS-COV-2. Furthermore, 20-hydroxyPGF2α and 14(15)-EpETE show promise as potential biomarkers for SARS-CoV-2-induced thrombosis.

摘要

血栓形成是严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染中一种危及生命的并发症。本研究旨在对住院的SARS-CoV-2患者的血栓发生率和血脂浓度进行统计分析,并研究氧化脂质网络。1731例住院的SARS-CoV-2患者的血清样本用于测量六个脂质参数:总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、载脂蛋白A(apoA)和载脂蛋白B(apoB)。此外,通过液相色谱-电喷雾电离-串联质谱(LC-MS/MS)对有血栓形成和无血栓形成的SARS-CoV-2阳性患者的血脂谱和氧化脂质组学特征进行了检测。SARS-CoV-2血栓形成组的死亡率显著高于SARS-CoV-2非血栓形成组,分别为29.6%和12.1%(P<0.0001)。脂质参数水平与血栓形成和SARS-CoV-2严重程度密切相关。与对照组相比,住院的SARS-CoV-2患者的氧化脂质代谢产物出现了显著变化,特别是花生四烯酸(ARA)和二十二碳六烯酸(DHA)类。在血栓组中,发现与非血栓组相比有28种氧化脂质代谢产物差异表达,其中20-羟基PGF2α和14(15)-EpETE的变化最为显著。使用KEGG进行的富集分析表明,差异氧化脂质代谢产物主要集中在ARA和5-羟色胺能突触代谢信号通路。我们的研究结果表明脂质介质与SARS-CoV-2和血栓之间存在密切关联。具体而言,ARA和5-羟色胺能突触代谢信号通路可能是SARS-CoV-2导致血栓形成的重要致病因素。此外,20-羟基PGF2α和14(15)-EpETE有望作为SARS-CoV-2诱导血栓形成的潜在生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d0/12397397/f7348e13b832/41598_2025_17722_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d0/12397397/93afaad532bc/41598_2025_17722_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d0/12397397/7ecdaae932b4/41598_2025_17722_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d0/12397397/48a681d754ec/41598_2025_17722_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d0/12397397/a8fb629d10f0/41598_2025_17722_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d0/12397397/795f43f9db90/41598_2025_17722_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d0/12397397/f7348e13b832/41598_2025_17722_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d0/12397397/93afaad532bc/41598_2025_17722_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d0/12397397/7ecdaae932b4/41598_2025_17722_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d0/12397397/48a681d754ec/41598_2025_17722_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d0/12397397/a8fb629d10f0/41598_2025_17722_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d0/12397397/795f43f9db90/41598_2025_17722_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d0/12397397/f7348e13b832/41598_2025_17722_Fig6_HTML.jpg

相似文献

[1]
Profiling of lipid mediators and oxylipins in SARS-CoV-2 infection associated thrombosis.

Sci Rep. 2025-8-29

[2]
Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.

Cochrane Database Syst Rev. 2022-5-6

[3]
Remdesivir for the treatment of COVID-19.

Cochrane Database Syst Rev. 2023-1-25

[4]
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.

Cochrane Database Syst Rev. 2022-5-20

[5]
Prescription of Controlled Substances: Benefits and Risks

2025-1

[6]
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.

Cochrane Database Syst Rev. 2021-9-2

[7]
Enhanced Production of Lipid Mediators in Plasma and Activation of DNA Damage Pathways in PBMCs Are Correlated With the Severity of Ancestral SARS-CoV-2 Infection.

FASEB J. 2025-5-15

[8]
Accuracy of routine laboratory tests to predict mortality and deterioration to severe or critical COVID-19 in people with SARS-CoV-2.

Cochrane Database Syst Rev. 2024-8-6

[9]
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.

Cochrane Database Syst Rev. 2022-7-22

[10]
RETRACTED: The effects of Implanon on lipid metabolism in comparison with Norplant.

Contraception. 1999-11

本文引用的文献

[1]
Icosapent ethyl reduces arterial thrombosis by inhibition of cyclooxygenase-1-induced platelet reactivity.

Sci Transl Med. 2025-5-21

[2]
Long-chain polyunsaturated fatty acid-containing phosphatidylcholines predict survival rate in patients after heart failure.

Heliyon. 2024-10-30

[3]
KEGG: biological systems database as a model of the real world.

Nucleic Acids Res. 2025-1-6

[4]
SPMs exert anti-inflammatory and pro-resolving effects through positive allosteric modulation of the prostaglandin EP4 receptor.

Proc Natl Acad Sci U S A. 2024-10-8

[5]
Omega-3 Fatty Acids and Markers of Thrombosis in Patients with Atrial Fibrillation.

Nutrients. 2024-1-5

[6]
Role of Polyunsaturated Fat in Modifying Cardiovascular Risk Associated With Family History of Cardiovascular Disease: Pooled De Novo Results From 15 Observational Studies.

Circulation. 2024-1-23

[7]
The oxylipin analog CS585 prevents platelet activation and thrombosis through activation of the prostacyclin receptor.

Blood. 2023-11-2

[8]
Resolvin D2 Attenuates Cardiovascular Damage in Angiotensin II-Induced Hypertension.

Hypertension. 2023-1

[9]
Urinary lipid profile of patients with coronavirus diseases 2019.

Front Med (Lausanne). 2022-9-26

[10]
Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales.

Circulation. 2022-9-20

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索